{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:59:34Z","timestamp":1792202374284,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["81973397"],"award-info":[{"award-number":["81973397"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFC2008301"],"award-info":[{"award-number":["2020YFC2008301"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007835","name":"Wenzhou Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.fct.2023.114065","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T15:38:14Z","timestamp":1695742694000},"page":"114065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine"],"prefix":"10.1016","volume":"181","author":[{"given":"Xiaodan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5716-8617","authenticated-orcid":false,"given":"Sen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaozhi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2023.114065_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/bcp.13821","article-title":"Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: clinically significant drug-drug interaction?","volume":"85","author":"Abdullahi","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2023.114065_bib2","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2217\/pgs-2020-0081","article-title":"Effect of CYP3A5*3 genotypes on lumefantrine plasma concentrations among malaria-HIV-infected women","volume":"21","author":"Adegbola","year":"2020","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fct.2023.114065_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071800","article-title":"Novel therapeutics for malaria","volume":"15","author":"Alaithan","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.fct.2023.114065_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40902-021-00300-y","article-title":"Adverse reaction to Coartem (artemether\/lumefantrine) resulting in oculogyric crisis","volume":"43","author":"Amponsah","year":"2021","journal-title":"Maxillofac Plast Reconstr Surg"},{"key":"10.1016\/j.fct.2023.114065_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12936-023-04581-8","article-title":"Cost of inappropriate prescriptions for uncomplicated malaria in Ghana","volume":"22","author":"Aryeetey","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2023.114065_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-3156.2006.01784.x","article-title":"How much fat is necessary to optimize lumefantrine oral bioavailability?","volume":"12","author":"Ashley","year":"2007","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.fct.2023.114065_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12936-023-04650-y","article-title":"Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: a prospective, real-world study in sub-Saharan Africa","volume":"22","author":"Baraka","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2023.114065_bib8","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4269\/ajtmh.21-1297","article-title":"Safety, tolerability, and parasite clearance kinetics in controlled human malaria infection after direct venous inoculation of Plasmodium falciparum sporozoites: a model for evaluating new blood-stage antimalarial drugs","volume":"107","author":"Chughlay","year":"2022","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.fct.2023.114065_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fgene.2013.00017","article-title":"Characterization of the genetic variation present in CYP3A4 in three South African populations","volume":"4","author":"Drogemoller","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.fct.2023.114065_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1128\/AAC.44.3.697-704.2000","article-title":"Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria","volume":"44","author":"Ezzet","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2023.114065_bib11","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.2147\/DDDT.S152366","article-title":"Functional assessment of CYP3A4 allelic variants on lidocaine metabolism in vitro","volume":"11","author":"Fang","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.fct.2023.114065_bib12","article-title":"The influence of CYP3A4 genetic polymorphism and proton pump inhibitors on osimertinib metabolism","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.fct.2023.114065_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12936-023-04705-0","article-title":"The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso","volume":"22","author":"Guissou","year":"2023","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2023.114065_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3389\/fgene.2019.00224","article-title":"Polymorphism in cytochrome P450 3A4 is ethnicity related","volume":"10","author":"Guttman","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.fct.2023.114065_bib15","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2217\/pgs-2016-0179","article-title":"Systematic screening for CYP3A4 genetic polymorphisms in a Han Chinese population","volume":"18","author":"Hu","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.fct.2023.114065_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12879-016-1345-1","article-title":"The interaction between artemether-lumefantrine and lopinavir\/ritonavir-based antiretroviral therapy in HIV-1 infected patients","volume":"16","author":"Kredo","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.fct.2023.114065_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7108a1","article-title":"Malaria surveillance - United States, 2018","volume":"71","author":"Mace","year":"2022","journal-title":"MMWR Surveill Summ"},{"issue":"Suppl. 1","key":"10.1016\/j.fct.2023.114065_bib18","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","article-title":"The clinical efficacy of artemether\/lumefantrine (Coartem)","volume":"8","author":"Makanga","year":"2009","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2023.114065_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12936-020-03520-1","article-title":"Asymptomatic recrudescence after artemether-lumefantrine treatment for uncomplicated falciparum malaria: a systematic review and meta-analysis","volume":"19","author":"Mumtaz","year":"2020","journal-title":"Malar. J."},{"key":"10.1016\/j.fct.2023.114065_bib20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.fct.2023.114065_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1124\/dmd.119.088062","article-title":"Pregnancy and CYP3A5 genotype affect day 7 plasma lumefantrine concentrations","volume":"47","author":"Mutagonda","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.fct.2023.114065_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/14760584.2023.2245890","article-title":"Sporozoite immunization: innovative translational science to support the fight against malaria","author":"Richie","year":"2023","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.fct.2023.114065_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207671","article-title":"Characterization of ADME genes variation in Roma and 20 populations worldwide","volume":"13","author":"Skaric-Juric","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.fct.2023.114065_bib24","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1128\/AAC.01700-12","article-title":"Effect of single nucleotide polymorphisms in cytochrome P450 isoenzyme and N-acetyltransferase 2 genes on the metabolism of artemisinin-based combination therapies in malaria patients from Cambodia and Tanzania","volume":"57","author":"Staehli Hodel","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.fct.2023.114065_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bcp.15001","article-title":"The pharmacokinetic properties of artemether and lumefantrine in Malaysian patients with Plasmodium knowlesi malaria","volume":"88","author":"Sugiarto","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.fct.2023.114065_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jphs.2020.07.013","article-title":"Effect of nevirapine, efavirenz and lopinavir\/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria","volume":"144","author":"Usman","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.fct.2023.114065_bib27","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/clpt.2014.129","article-title":"Functional gene variants of CYP3A4","volume":"96","author":"Werk","year":"2014","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.fct.2023.114065_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.pt.2008.01.006","article-title":"Simplified antimalarial therapeutic monitoring: using the day-7 drug level?","volume":"24","author":"White","year":"2008","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.fct.2023.114065_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113669","article-title":"Effect of flavonoids and CYP3A4 variants on midostaurin metabolism","volume":"174","author":"Xu","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.fct.2023.114065_bib30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3389\/fphar.2019.00591","article-title":"Enzymatic activities of CYP3A4 allelic variants on quinine 3-hydroxylation in vitro","volume":"10","author":"Zhou","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523004672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523004672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:12:33Z","timestamp":1736345553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691523004672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"alternative-id":["S0278691523004672"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2023.114065","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determine the enzymatic kinetic characteristics of CYP3A4 variants utilizing artemether-lumefantrine","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.114065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114065"}}